Screening Protocol for Research Participants

Completed

• Conditions: Cocaine Abuse; Tobacco Use Disorder; Schizophrenia; Substance Abuse
• Interventions: Behavioral: Various Screening psychiatric and medical assessments

• Registration Number: NCT01010620
• Lead Sponsor: University of Maryland, Baltimore

Brief Summary

The Screening Protocol is a system devised to evaluate potential research participants for National Institute on Drug Abuse/Maryland Psychiatric Research Center (NIDA/MPRC) studies.

Detailed Description

The MPRC/NIDA collaborative research program attempts to: elucidate the nature of serious mental illnesses, drug abuse and addiction; determine the potential use of new therapies, both pharmacological and psychosocial; and decipher the long-term effects of drugs of abuse on the development, maturation, function, and structure of the brain and other organ systems. In support of this work, the scientific goal of this screening protocol is to assess potential research participants' eligibility for research studies. Screening will include medical and psychological tests and procedures. The data collected during screening are a unique and valuable source of information that aids in the research mission. Therefore, a secondary goal of this protocol is to obtain data that characterizes the population of subjects contacting NIDA about research participation and to analyze data so obtained, such as that on the prevalence and consequences of HIV/AIDS, viral hepatitis, and related diseases and issues of selection and sample bias in clinical research.

The screening process will be done in two stages, a telephone interview and an in-person evaluation. The telephone interview will last approximately 20 minutes and be conducted solely via the NIDA call center. Answers provided during the phone interview will indicate whether a caller is eligible for in-person screening. Those who appear eligible will be given an appointment at either NIDA or MPRC. This protocol pertains only to the in-person participants at MPRC. Written informed consent will be obtained when the person arrives. The screening process can involve up to 5 visits to MPRC.

Study Timeline

• Study First Submitted: 2009-07-08
• Study First Submitted QC: 2009-11-09
• Study First Posted: 2009-11-10
• Study Start: 2009-12
• Primary Completion: 2019-06-01
• Study Completion: 2019-06-01
• Status Verified: 2019-08
• Last Update Submitted: 2019-08-15
• Last Update Posted: 2019-08-19

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 523

Inclusion Criteria

• Age 18 or older
• Ability to read and understand and answer questions posed.

Exclusion Criteria

• Inability to provide valid informed consent
• Below Age 18, and above age 64.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Screening	Various Screening psychiatric and medical assessments	Screening Assessment battery. Specific to study(or studies) the individual is screening for.

Primary Outcome Measures

Name	Time	Method
Recruitment of participants into NIDA/MPRC protocols.	5 years

Secondary Outcome Measures

Name	Time	Method
Demographic characterization of drug users, non-users, and individuals with serious mental illnesses contacting NIDA/MPRC about research participation	5 year

Trial Locations

Locations (1)

Maryland Psychiatric Research Center; 🇺🇸 Catonsville, Maryland, United States